solutions or suspensions may also contain a long-chain alcohol diluent or dispersant, such as carboxymethyl cellulose or similar dispersing agents which are commonly used in the formulation of pharmaceutically acceptable dosage forms including emulsions and suspensions. Other commonly used surfactants, such ...
These oil solutions or suspensions may also contain a long-chain alcohol diluent or dispersant, such as carboxymethyl cellulose or similar dispersing agents which are commonly used in the formulation of pharmaceutically acceptable dosage forms including emulsions and suspensions. Other commonly used ...
The protein complexes were screened for crystallization in sitting drops using the Phoenix robot (Art Robbins) and commercial screening solutions. Crystallization droplets consisted of 0.2μL protein and 0.2 μL reservoir at 18 and 4 °C. The 5B3.v3/E2 complex crystallized after 2 days with 0.1...
Terms such as "a", "an" and "the" are not intended to refer to only a singular entity, but include the general class of which a specific example may be used for illustration. The terminology herein is used to describe specific embodiments of the invention, but their usage does not ...
11. A process according to claim 10, wherein R1 is methyl. 12. A process for of claim 10 comprising using compound (IX) as an intermediate in the synthesis of (I). 13. (canceled) Description: FIELD OF THE INVENTION The present invention relates to synthesis procedures and synthesis in...
Example 11 Preparation of the Compound of Formula (XI) 11.49 g (34.58 mmol) of the compound of formula (VIII) and 9.52 g (36.30 mmol) triphenylphosphine were added to a solution of the compound of formula (VII) in toluene (34.58 mmol compound of formula (VII) for 184.86 g solution). ...